Intraperitoneal erythropoietin treatment of children with chronic renal failure

B T Steele1, A Vigneux

  • 1Department of Paediatrics, McMaster University Medical Centre, Hamilton, Ontario, Canada.

Insights

Intraperitoneal erythropoietin effectively improved hemoglobin in children on peritoneal dialysis over six months. This method is cost-effective and avoids the pain associated with subcutaneous injections.

Area of Science:

  • Pediatric Nephrology
  • Renal Replacement Therapy
  • Hematology

Background:

  • Chronic kidney disease in children often leads to anemia.
  • Erythropoietin is a standard treatment for anemia in dialysis patients.
  • Subcutaneous administration of erythropoietin can cause local pain and discomfort.

Purpose of the Study:

  • To evaluate the efficacy and safety of intraperitoneal erythropoietin administration in children undergoing chronic peritoneal dialysis.
  • To assess the cost-effectiveness of the intraperitoneal route compared to subcutaneous administration.

Main Methods:

  • Three children on chronic peritoneal dialysis received intraperitoneal erythropoietin.
  • Doses ranged from 100 to 150 units/kg, administered undiluted into a dry peritoneal cavity twice weekly.
  • Erythropoietin remained in the cavity for 10-12 hours before resuming dialysis.

Main Results:

  • Satisfactory hemoglobin levels were achieved and maintained over a 6-month study period.
  • No complications related to intraperitoneal erythropoietin administration were observed.
  • The intraperitoneal route demonstrated cost-effectiveness.

Conclusions:

  • Intraperitoneal erythropoietin is a safe and effective alternative for managing anemia in pediatric patients on peritoneal dialysis.
  • This administration route offers a cost-effective solution and improves patient comfort by avoiding subcutaneous injection pain.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...